CD8A and glioma: Upon intratumoral administration to orthotopic gliomas, 7aaRGD shifts the glioma TME toward a “hot” phenotype by blocking the reprogramming of GAMs, increasing the percentage of CD8 + T cells among infiltrating lymphocytes, and normalizing the tumor vasculature.